Toll-like receptor 5 gene polymorphism is associated with breast cancer susceptibility

Toll-like receptor 5 (TLR5) plays a fundamental role in immune responses. Recent findings suggest the TLR5 expression level affects cancer progression and development. In the present study, our examination of 256 breast carcinomas specimens revealed that TLR5 is overexpressed in breast carcinomas, and that TLR5 overexpression correlated with lymph node metastasis and cancer grade (p<0.01). In a case-control study, we also analyzed associations between TLR5 single nucleotide polymorphisms (SNPs) and breast cancer risk. Compared were 516 Chinese Han women diagnosed mainly with infiltrative ductal carcinoma and 520 age-matched healthy controls. The nonsense SNP rs5744168 causes truncation of the TLR5 transmembrane signaling domain and was associated with breast cancer risk (p<0.05). However, no statistical association was detected between SNP rs5744168 and any of the clinical parameters tested. Our findings thus indicate that TLR5 SNP rs5744168 is associated with sporadic breast cancer occurrence.

[1]  G. Barber.  STING: infection, inflammation and cancer , 2015, Nature Reviews Immunology.

[2]  Chen Wangyang,et al.  SNP-SNP interactions of immunity related genes involved in the CD28/B7 pathway with susceptibility to invasive ductal carcinoma of the breast. , 2015, Gene.

[3]  C. Haglund,et al.  The expression of Toll-like receptors 2, 4, 5, 7 and 9 in Merkel cell carcinoma. , 2015, Anticancer research.

[4]  N. Meena,et al.  Association of TLR5 Gene Polymorphisms in Ulcerative Colitis Patients of North India and Their Role in Cytokine Homeostasis , 2015, PloS one.

[5]  G. Rabinovich,et al.  Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. , 2015, Cancer cell.

[6]  Shuji Ogino,et al.  Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy. , 2014, World journal of gastroenterology.

[7]  Jochen Hampe,et al.  Functional TLR5 genetic variants affect human colorectal cancer survival. , 2013, Cancer research.

[8]  M. Clerici,et al.  A Nonsense Polymorphism (R392X) in TLR5 Protects from Obesity but Predisposes to Diabetes , 2013, The Journal of Immunology.

[9]  T. Salo,et al.  Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue , 2013, British Journal of Cancer.

[10]  P. Lehenkari,et al.  Increased Toll-like receptor 5 expression indicates esophageal columnar dysplasia , 2013, Virchows Archiv.

[11]  P. Simpson,et al.  A TLR5 (g.1174C > T) variant that encodes a stop codon (R392X) is associated with bronchopulmonary dysplasia , 2012, Pediatric pulmonology.

[12]  Mingyao Liu,et al.  Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth. , 2011, Cancer research.

[13]  J. Bates,et al.  Flagellin as an Adjuvant: Cellular Mechanisms and Potential , 2010, The Journal of Immunology.

[14]  S. Akira,et al.  Immune responses of TLR5+ lamina propria dendritic cells in enterobacterial infection , 2009, Journal of Gastroenterology.

[15]  L. Zhao,et al.  Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women , 2009, PloS one.

[16]  T. Hawn,et al.  Toll-like receptor polymorphisms and susceptibility to human disease. , 2008, Clinical science.

[17]  Judy H Cho,et al.  Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[18]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[19]  A. Aderem,et al.  A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Müller-Hermelink,et al.  Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. , 2005, International journal of medical microbiology : IJMM.

[21]  S. Mizel,et al.  Effects of flagellin on innate and adaptive immunity , 2005, Immunologic research.

[22]  Richard J. Laws,et al.  A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease , 2003, The Journal of experimental medicine.